Target intelligence / Profile preview

SH3 domain containing GRB2 like 1, endophilin A2 pseudogene 1 (SH3GL1P1)

Target: SH3GL1P1
Molecular classification: Other (Pseudogene)

Overview

SH3GL1P1 (SH3 domain containing GRB2 like 1, endophilin A2 pseudogene 1), also referenced as CNSA-P1, is a pseudogene, meaning it is a segment of DNA that resembles a gene but does not encode a functional protein. It is related by sequence similarity to the SH3GL1 gene, which encodes endophilin A2, a protein involved in endocytosis and membrane trafficking in cells. SH3GL1P1 is thus believed to be a nonfunctional genomic remnant and is not a known drug target, functional receptor, or enzyme relevant in human disease or therapy[3][4].

Other names: CNSA-P1

Beyond the preview

Go deeper on SH3 domain containing GRB2 like 1, endophilin A2 pseudogene 1 (SH3GL1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SH3 domain containing GRB2 like 1, endophilin A2 pseudogene 1 (SH3GL1P1).

Explore the full profile